Am Fam Physician. 2007 Nov 1;76(9):1402.
Guideline source: Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices
Literature search described? No
Evidence rating system used? No
Published source: Morbidity and Mortality Weekly Report, August 10, 2007
The Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention has expanded its recommendations on vaccination with quadrivalent meningococcal conjugate vaccine (MCV4; Menactra). All persons 11 to 18 years of age should be routinely vaccinated with one dose of MCV4 as early as possible. ACIP continues to recommend routine vaccination for persons 19 to 55 years of age who are at increased risk for meningococcal disease: college freshmen living in dormitories, microbiologists routinely exposed to isolates of Neisseria meningitidis, military recruits, travelers to or residents of countries in which N. meningitidis meningitis is hyperendemic or epidemic, persons with terminal complement component deficiencies, and persons with anatomic or functional asplenia.
Supply of MCV4 was limited in 2005 and 2006 because demand for the vaccine peaked in months when children were returning to school after summer vacation. As a result of the new recommendations, ACIP now expects supply of MCV4 to be sufficient to meet demand. ACIP encourages physicians to vaccinate with MCV4 throughout the year to minimize seasonal increases in demand during July and August. MCV4 and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine should be given to persons 11 to 18 years of age during the same visit if both vaccines are indicated.
Copyright © 2007 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact email@example.com for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions